Search for the Role of Immunotherapy with Corynebacterium Parvum Intrapleurally in Operable Bronchial Non-Small-Cell Carcinoma

Abstract

The emphasis of the title lies upon “Search,” since it cannot be expected that an answer to the crucial question whether or not immunotherapy is a meaningful therapeutic tool in managing patients with lung cancer, will be found in this communication.

Members of the study group: Drs. J. STJERNSWÄRD, M. KAUFMANN (Ludwig Institute for Cancer Research Lausanne Branch, Switzerland), M. ZELEN, K. STANLEY (Frontier Science and Technology Research Foundation, Inc. Amherst, New Yoek, USA), D.S. FREESTONE, R. BOMFORD, M.T. SCOTT, T. PRIESTMAN (Wellcome Research Laboratory, Beckenham, England), C. MOURITZEN, G. AHLBOM (Dept. of Thoracic and Cardiovascular Surgery, Aarhus Kommunehospital, Aarhus, Denmark), N. KONIETZKO, D. GRESCHUCHNA (Ruhrland Clinic, Essen-Haidhausen, Germany), P. HILGARD (Innere Klinik und Poliklinik (Tumorforschung) Essen, Germany), J. VOGT-MOYKOPF, D. ZEIDLER, H. TOOMES (Thorax Chirurgische Special Klinik, Heidelberg, Germany), F. KRAUSE, R. RIOS (Thoraxchirurgische Abt., Fachkrankenhaus für Lungen- und Bronchialerkrankungen, Löwenstein, Germany), J. OREL, M. BENEDIK, B. HRABAR (Clinical Center, Dept. of Thoracic Surgery, Ljubljana, Yugoslavia), S. PLESNICAR (Institute of Oncology, Ljubljana, Yugoslavia), H.A. ROSTAD, J.R. VALE (Riks Hospitalet, Oslo, Norway), S. HAGEN, D. BIRKELAND (Ulleval Hospital, Oslo, Norway), T. HARBITZ, R. NISSEN-MEYER (Akers Hospital, Oslo, Norway), L. RODRIGUEZ, V.O. BJÖRK, K. BOOK (Karolinska Sjukhuset, Thoracic Clinic, Stockholm, Sweden), E. GRADEL, J. HASSE, P. HOLBRO (Kantonspital, Thoraxchirurgische Klinik, Basel, Switzerland), L. ECKMANN (Tiefenauspital, Chir. Univ. Klinik, Bern, Switzerland), B. NACHBUR, T. LIECHTI (Inselspital, Dept. of Thoracic and Cardiovascular Surgery, Bern, Switzerland), H. COTTIER (Inst, of Pathology, Inselspital, Bern, Switzerland), W. MAURER, M. KAUFMANN, P. FROELICHER (Burgerspital, Surgical Dept., Solothurn, Switzerland), T.H. DENCK, N. PRIDUN (Krankenhaus der Stadt Wien-Lainz, Chir. Abt., Vienna, Austria), K. KARRER (Institute for Cancer Research, University of Vienna, Austria).

Reported by Dr. N. KONIETZKO, P.D., Essen.

Request for reprints: to any of the members listed above, or to the Operation Office, LUDWIG LUNG CANCER TRIAL, LICR, CH-1006 EPALINGES, Switzerland. (For Current Contents, etc. please use above address).